Published on
A Penn Medicine and CHOP team will seek to develop treatments for three rare, incurable genetic diseases with the help of a $26 million grant from the National Institutes of Health.
Published on
On May 25, 2023, Office of Diversity, Equity and Inclusion (ODEI) at Children’s Hospital of Philadelphia held its inaugural DEI Breakthrough Makers Summit. This hybrid event was attended by more than 350 CHOP employees and raised awareness and understanding of DEI initiatives at CHOP.
Published on
CHOP and Penn researchers have developed a proof-of-concept model for delivering gene editing tools to treat blood disorders directly within the body.
Published on
For the third year in a row, Children’s Hospital of Philadelphia (CHOP) has been selected as one of the 50 most community-minded companies in Pennsylvania, New Jersey and Delaware for 2023.
Published on
In the largest study of its kind, CHOP researchers have validated a population-level pattern of pediatric allergy development known as the “allergic march.”
Published on
Multi-million dollar gift from The Wawa Foundation brings Coffee and Care Cart to CHOP’s second inpatient hospital, offering comfort to patients and families, while helping to expand Wawa Volunteer Services program.
Published on
“Nudges” from electronic health records could improve the implementation of tobacco use treatment almost three-fold over standard care.
Published on
CHOP researchers have shown that NSAIDs disrupt epithelial cells in the colon and sensitize them to C. difficile toxins by perturbing cell mitochondria.
Published on
Children’s Hospital of Philadelphia (CHOP) researcher Riccardo Gottardi, PhD has been named a “Young Innovator of Cellular and Molecular Bioengineering” by Cellular and Molecular Bioengineering, the official journal of the Biomedical Engineering Society.
Published on
Tool may be more accurate than existing methods and was made possible through a cohort of tens of thousands of patients from different backgrounds around the world.